How to Switch from Ozempic to Foundayo (Orforglipron)

Foundayo (orforglipron) was FDA-approved in March 2026 as the first non-peptide oral GLP-1 receptor agonist for weight management. Unlike Ozempic, which requires weekly injections, Foundayo is a daily pill that can be taken at any time of day without food or water restrictions.

Key reasons patients switch:

• No more injections — Foundayo is a once-daily pill, not a weekly injection
• No food restrictions — Unlike Rybelsus (oral semaglutide), Foundayo can be taken with food and water
• Lower cost — Foundayo's list price is significantly lower than Ozempic, and Lilly's savings card brings it to $25/month for eligible patients
• Convenience — No cold storage, no needles, easy to travel with
• Comparable efficacy — Phase 3 ATTAIN-1 trial showed 12.4% body weight loss (27 lbs average) at the highest dose over 72 weeks

The main consideration: Foundayo is a GLP-1 partial agonist (not full agonist like semaglutide), which means the pharmacology is slightly different. Most patients tolerate the switch well, with transient GI side effects during the first 2-4 weeks.

There's no exact 1:1 dose conversion between Ozempic (semaglutide) and Foundayo (orforglipron) because they work through different mechanisms — semaglutide is a full GLP-1 agonist while orforglipron is a partial agonist.

However, based on clinical trial efficacy data, here are the approximate equivalences:

Ozempic Dose	Foundayo Equivalent	Notes
0.25mg	Start at 0.8mg	Both are starter doses
0.5mg	Start at 0.8mg, titrate to 2.5mg	4+ weeks on starting dose recommended
1.0mg	Titrate to 5.5-9mg	May take 8-12 weeks to reach equivalent efficacy
2.0mg	Titrate to 14.5-17.2mg	Highest Foundayo doses; titration takes 16-20 weeks

Important: Regardless of your Ozempic dose, most doctors will start you at Foundayo 0.8mg and titrate up every 30+ days. This minimizes GI side effects and allows your body to adjust to the new medication.

The switch from Ozempic to Foundayo is a direct switch — no washout period needed. Here's what a typical timeline looks like:

Week 1: Take your last Ozempic injection. Start Foundayo 0.8mg daily the next day.

Weeks 1-4: Transient GI symptoms are common (nausea, mild diarrhea) as your body adjusts. These are typically milder than what you experienced when first starting Ozempic. Ozempic's long half-life (7 days) means there's overlap coverage during the first week.

Week 5+: Your doctor increases Foundayo to 2.5mg. Continue titrating up every 30+ days until reaching your maintenance dose.

Months 2-5: Gradual titration through 5.5mg → 9mg → 14.5mg → 17.2mg (max). Not everyone needs the highest dose — your doctor will find the right balance of efficacy and tolerability.

Expected weight change during transition: Based on GLP-1 class switching data, approximately 2 lbs (0.9kg) of temporary weight regain is expected during the transition period. This is temporary and reverses once you reach an effective Foundayo dose.

Cost is one of the biggest reasons patients switch. Here's the breakdown:

Ozempic: List price ~$936/month. With Novo Nordisk savings card: $25/month (for commercially insured patients). Medicare: varies by plan.

Foundayo: List price ~$149-349/month (dose-dependent). With Lilly savings card: $25/month (for eligible insured patients). Lilly has committed to competitive pricing given Foundayo's lower manufacturing cost as a small molecule.

Even at list price, Foundayo saves roughly $537/month compared to Ozempic. For uninsured patients or those whose insurance doesn't cover GLP-1s, this difference is significant.

Additionally, Foundayo is a small molecule (not a biologic), which means compounding is not needed — the retail price is already competitive with compounded semaglutide.

Both Ozempic and Foundayo cause GI side effects (it's the nature of GLP-1 medications), but the profiles differ:

Generally better on Foundayo:

• Lower overall nausea rate (25% vs 20% for Ozempic)
• Shorter duration of GI symptoms for most patients
• No injection site reactions (obviously)

New or different on Foundayo:

• Dyspepsia (heartburn/indigestion) — 9% incidence
• GERD (acid reflux) — 4% incidence
• Hair thinning — reported in ~3% of patients in trials

During the transition: Expect 2-4 weeks of adjustment. GI symptoms are typically mild and transient. Taking Foundayo with food may help reduce nausea.